This open label, single arm, clinical interventional study, aims to investigate whether Individualized Homeopathic Medicine can effectively reduce symptoms associated with substance-induced psychotic disorder (SIPD). SIPD is a condition where individuals experience delusions and hallucinations as a result of substance use. Currently, there is limited research on specific treatments for SIPD, and conventional treatments often focus on managing symptoms rather than addressing the underlying causes. Homeopathy, which takes a holistic approach to health, offers a potential alternative.

The research team plans to enroll 35 participants aged 18 to 60 who have symptoms of SIPD. Participants will undergo detailed screening and assessment to confirm the diagnosis and ensure they meet the study criteria. Those eligible will receive individualized homeopathic treatment based on their unique symptoms, as determined through comprehensive case-taking and analysis.

The severity of participants’ symptoms will be assessed using the Brief Psychiatric Rating Scale (BPRS) at the beginning of the study and regularly throughout the 12-month follow-up period. Additionally, changes in participants’ quality of life will be measured using the World Health Organization Quality of Life (WHOQOL-BREF) scale.

The research team will closely monitor participants’ progress and adjust treatment as needed. Participants who experience adverse reactions or serious events will receive appropriate support and care. To maintain ethical standards, informed consent will be obtained from all participants, and confidentiality will be strictly maintained.